Status:
RECRUITING
Intraosseous Morphine Administration During Anterior Cruciate Ligament Reconstruction
Lead Sponsor:
The Methodist Hospital Research Institute
Conditions:
Anterior Cruciate Ligament Tear
Anterior Cruciate Ligament Injuries
Eligibility:
All Genders
18-40 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine if intraosseous (IO) morphine decreases pain and post-operative opioid use in patients undergoing anterior cruciate ligament (ACL) reconstruction.
Eligibility Criteria
Inclusion
- Patients of the IRB approved surgeon(s) undergoing ACL reconstruction with bone-to-bone (BTB) autograft
- Patients aged between 18-40 years old at the time of surgery
Exclusion
- Patients undergoing ACL reconstruction with any other type of autograft or allograft other than BTB
- Patients younger than 18 years old or older than 40 years old
- Patients undergoing meniscal root repair or any other repair that changes their weight-bearing status
- Patients with a history of substance abuse
- Vulnerable populations
- Patients on chronic pain medication within the last 6 months
- BMI \>/= 35
- Allergy to morphine
- Unwilling to participate
- Any additional reason the PI deems reasonable
Key Trial Info
Start Date :
August 19 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2029
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT06511232
Start Date
August 19 2024
End Date
July 31 2029
Last Update
November 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Houston Methodist Research Institute
Houston, Texas, United States, 77030